Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Lett Appl Microbiol ; 73(2): 168-175, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33893654

RESUMEN

The susceptibility of Acinetobacter baumannii exposed to primary antibiotic can be either increased or decreased when exposed to secondary antibiotic. This study was designed to assess the relative fitness, collateral susceptibility and collateral resistance of polymyxin B- (PMB-) adapted A. baumannii to ciprofloxacin (CIP), meropenem (MER), PMB, tetracycline (TET) and tobramycin (TOB). Strains of wild-type A. baumannii KACC 12454 (ABKACC ), wild-type A. baumannii CCARM 12088 (ABCCARM ), PMB-adapted ABKACC , PMB-adapted ABCCARM , stabilized ABKACC and stabilized ABCCARM were used in this study. Compared to the wild-type ABKACC , the MICs of PMB were increased from 2 to 128 µg ml-1 against PMB-adapted ABKACC , while MICs of CIP, MER, TET and TOB were decreased from 2 to 1 µg ml-1 , 16 to 1 µg ml-1 , 16 to 2 µg ml-1 and 64 to 16 µg ml-1 , respectively. The PMB-adapted ABCCARM was resistant to CIP (32 µg ml-1 ) and PMB (64 µg ml-1 ) compared to the wild-type ABCCARM . The resistance of stabilized ABKACC and ABCCARM to all antibiotics was lost after antibiotic-free culture in the exception of CIP and TET. The susceptibilities of wild-type, PMB-adapted and stabilized ABKACC and ABCCARM to CIP, MER, PMB, TET and TOB were increased in the presence of ß-lactamase and efflux pump inhibitors. The high levels of relative fitness were observed for stabilized ABKACC , PMB-adapted ABCCARM and stabilized ABCCARM . The stabilized ABKACC and PMB-adapted ABCCARM were highly heteroresistance to PMB and TET, respectively. The PMB-adapted ABKACC and ABCCARM showed various antibiotic patterns, known as collateral susceptibility and collateral resistance. The results provide useful information for designing effective antibiotic regimens that can enhance the antibiotic activity against A. baumannii infections.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Adaptación Biológica , Antibacterianos/farmacología , Sensibilidad Colateral al uso de Fármacos , Infecciones por Acinetobacter/tratamiento farmacológico , Infecciones por Acinetobacter/microbiología , Ciprofloxacina/farmacología , Farmacorresistencia Bacteriana Múltiple , Humanos , Meropenem/farmacología , Pruebas de Sensibilidad Microbiana , Polimixina B/farmacología , Tetraciclina/farmacología , Tobramicina/farmacología , beta-Lactamasas/farmacología
2.
J Appl Microbiol ; 126(3): 894-904, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30358043

RESUMEN

AIMS: To evaluate the antimicrobial activities of an active compound isolated from the culture broth of Amphirosellinia nigrospora JS-1675 against various plant pathogenic bacteria and fungi. METHODS AND RESULTS: While screening for bioactive secondary metabolites from endophytic fungi, we found that A. nigrospora JS-1675 showed strong in vitro antibacterial activity against Ralstonia solanacearum. One compound (1) was isolated and identified as (4S, 5S, 6S)-5,6-epoxy-4-hydroxy-3-methoxy-5-methyl-cyclohex-2-en-1-one. Growth of most of the tested phytopathogenic bacteria was inhibited by compound 1 and the ethyl acetate (EtOAc) layer except Pseudomonas syringae pv. lachrymans. Compound 1 also inhibited the mycelial growth of several plant pathogenic fungi. Both compound 1 and the EtOAc layer reduced bacterial leaf spot disease in detached peach leaves. They also suppressed the development of bacterial wilt on tomato seedlings quite effectively. CONCLUSIONS: Amphirosellinia nigrospora JS-1675 showed antimicrobial activity against plant pathogenic bacteria and fungi by producing compound 1. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report on the occurrence of compound 1 in A. nigrospora JS-1675 and its efficacy against plant pathogenic bacteria and fungi. Their strong disease control efficacy against tomato bacterial wilt suggests that this fungus can be used as a microbial bactericide.


Asunto(s)
Antiinfecciosos/farmacología , Productos Biológicos/farmacología , Ciclohexanonas/farmacología , Enfermedades de las Plantas/microbiología , Xylariales/química , Bacterias/efectos de los fármacos , Hongos/efectos de los fármacos
3.
Lett Appl Microbiol ; 62(6): 488-93, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27105128

RESUMEN

UNLABELLED: The emergence of pathogenic bacterial strains resistant to agrochemicals and the increasing demand for organic foods have led to the discovery of new antibacterial metabolites that can be used either directly or as a lead molecule for development of synthetic bactericides. During the screening of antibacterial fungal cultures, we found that one fungal strain, Aspergillus persii EML-HPB1-11, showed strong in vitro antibacterial activity against Xanthomonas arboricola pv. pruni (Xap) with a minimum inhibitory concentration (MIC) of 10% of fermentation broth filtrate. The active compound was identified as penicillic acid (PA: 3-methoxy-5-methyl-4-oxo-2,5-hexadienoic acid) by mass and NMR spectroscopy. The in vitro antibacterial activity of PA was tested against 12 phytopathogenic bacteria. All of the bacterial pathogens tested were highly inhibited by PA with MIC values of 12·3-111·1 µg ml(-1) . It also effectively suppressed the development of bacterial spot disease in detached peach leaves, showing control values of 82·4 and 94·1% at concentrations of 111·1 and 333·3 µg ml(-1) respectively. This is the first report on the production of PA by A. persii. This study suggests that PA can be used as a lead molecule for development of synthetic bactericides for control of various plant diseases. SIGNIFICANCE AND IMPACT OF THE STUDY: Penicillic acid (PA) produced by the seed-borne fungus Aspergillus persii EML-HPB1-11 showed antibacterial activity against various plant pathogenic bacteria. The compound effectively inhibited the growth of 12 plant pathogenic bacteria and successfully controlled bacterial spot disease on peach leaf. These results suggest that PA can be used as a lead molecule for development of synthetic agrochemicals to control plant bacterial diseases.


Asunto(s)
Antibacterianos/farmacología , Aspergillus/metabolismo , Agentes de Control Biológico/farmacología , Ácido Penicílico/farmacología , Xanthomonas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Enfermedades de las Plantas/microbiología , Hojas de la Planta/microbiología , Plantas/microbiología , Semillas/microbiología
4.
Oral Dis ; 20(2): 191-204, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23496287

RESUMEN

OBJECTIVE: The purposes of this study were to isolate and characterize stem cells from inflamed pulp tissue of human functional deciduous teeth (iSHFD) and to evaluate the influence of fibroblastic growth factor-2 (FGF-2) on the regenerative potential. MATERIALS AND METHODS: We successfully isolated mesenchymal stem cells (MSCs) from the inflamed dental pulp tissue of human deciduous teeth and demonstrated that their regenerative potential could be enhanced by the application of FGF-2 (20 ng ml(-1)) during ex vivo expansion. Isolated stem cells expanded in FGF-2 were characterized using a colony-forming assay, proliferation, migration, in vitro differentiation, in vivo ectopic transplantation assay, and gene expression profiling. RESULTS: MSCs isolated from the inflamed pulp tissue of functional deciduous teeth potentially possess the qualities of those from human exfoliated deciduous teeth. FGF-2 applied to iSHFD during expansion enhanced the colony-forming efficiency of these cells, increased their proliferation and migration potential, and reduced their differentiation potential in vitro. However, the ectopic transplantation of iSHFD/FGF-2 in vivo increased the formation of dentin-like material. CONCLUSION: FGF-2 expansion of stem cells from inflamed pulp tissues of human deciduous teeth can be a good source of stem cells for future clinical applications and a novel way of using discarded inflamed tissues.


Asunto(s)
Pulpa Dental/citología , Factor 2 de Crecimiento de Fibroblastos/fisiología , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/fisiología , Pulpitis/patología , Diferenciación Celular , Células Cultivadas , Factor 2 de Crecimiento de Fibroblastos/farmacología , Humanos , Células Madre Mesenquimatosas/efectos de los fármacos , Diente Primario
5.
Andrologia ; 46(9): 1032-40, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24188423

RESUMEN

This study investigated the protective effects of melatonin (MT) against gentamicin (GM)-induced testicular toxicity and oxidative damage in rats. GM (100 mg kg(-1) ) was injected intraperitoneally (i.p.) to rats for 6 days. MT (15 mg kg(-1) ) was administered i.p. to rats for 6 days at 1 hr after the GM treatment. GM caused a decrease in prostate and seminal vesicle weights, sperm count and sperm motility. Histopathological examination showed various morphological alterations in the testis, characterised by degeneration of spermatogonia/spermatocytes, decrease in the number of early spermatogenic cells and vacuolisation. In addition, an increased malondialdehyde concentration and decreased glutathione content and glutathione reductase, catalase and glutathione-S-transferase activities were found in the testis. In contrast, MT treatment significantly attenuated the testicular toxicity of GM, including decreased reproductive organ weights, sperm count, and sperm motility and increased histopathological alterations. MT also had an antioxidant benefit by decreasing the lipid peroxidative product malondialdehyde and increasing the level of the antioxidant glutathione and the activities of antioxidant enzymes in the testis. These results indicate that MT prevents testicular toxicity induced by GM in rats, presumably due to its potent antioxidant activity, and its ability to inhibit lipid peroxidation, and restore antioxidant enzyme activity.


Asunto(s)
Antibacterianos/toxicidad , Antioxidantes/farmacología , Gentamicinas/antagonistas & inhibidores , Gentamicinas/toxicidad , Melatonina/farmacología , Testículo/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Testículo/metabolismo , Testículo/patología
6.
Biol Sport ; 31(1): 73-9, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25187675

RESUMEN

The study investigated the effect of high- and low-intensity exercise training on inflammatory reaction of blood and skeletal muscle in streptozotocin (STZ)-induced diabetic male Sprague-Dawley rats (243 ± 7 g, 8 weeks). The rats completed treadmill running in either high-intensity exercise (6 weeks of exercise training, acute bouts of exercise) or low-intensity exercise (6 weeks of exercise training). Non-running, sedentary rats served as controls. To induce diabetes mellitus, rats received a peritoneal injection of STZ (50 mg · kg(-1)). Rats were sacrificed immediately after an acute bout of exercise and 6 weeks of exercise training. Inflammatory factors were analyzed by ELISA and by immune blotting from the soleus and extensor digitorum longus muscles. In the serum, inflammatory cytokines (IL-1ß, TNF-α, IL-6, IL-4) and reactive oxygen species (ROS) (nitric oxide and malondialdehyde) increased in diabetic rats. However, all exercise training groups displayed reduced inflammatory cytokines and reactive oxygen species. In skeletal muscles, low-intensity exercise training, but not high intensity exercise, reduced the levels of COX-2, iNOS, and MMP-2, which were otherwise markedly elevated in the presence of STZ. Moreover, the levels of GLUT-4 and MyoD were effectively increased by different exercise intensity and exercise duration. Low-intensity exercise training appeared most effective to reduce diabetes-related inflammation. However, high-intensity training also reduced inflammatory factors in tissue-specific muscles. The data implicate regular exercise in protecting against chronic inflammatory diseases, such as diabetes.

7.
Scand J Immunol ; 78(5): 401-7, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23952047

RESUMEN

Receptor-interacting protein 2 (RIP2) is a caspase recruitment domain (CARD)-containing serine/threonine kinase that is activated by NOD1 or NOD2 recognition of their ligands and essential for the activation of NF-κB and mitogen-activated protein kinase (MAPK). RIP2 has been known to play an important role in innate immune responses against certain bacterial infection. However, the role and interplay of RIP2 with TLR signalling on cytokine production in macrophages against Yersinia enterocolitica infection remains poorly understood. In the present study, we examined whether RIP2 is essential for Yersinia-induced production of cytokines in macrophages. Our results showed that naïve RIP2-deficient macrophages produced similar level of IL-6, TNF-α and IL-10 upon Y. enterocolitica infection compared with wild-type macrophages. However, the production of IL-6, TNF-α and IL-10 by Y. enterocolitica was impaired in RIP2-deficient macrophages after lipopolysaccharide (LPS) pretreatment, a TLR4-tolerant condition. In addition, RIP2 inhibitors, SB203580, PP2, and gefitinib, reduced IL-6 production in TLR4-deficient macrophages in response to Y. enterocolitica, whereas they did not affect the cytokines production in WT cells. These results demonstrate that RIP2 may play an important role in proinflammatory cytokine production in macrophages at the absence of TLR signalling.


Asunto(s)
Interleucina-6/biosíntesis , Macrófagos/inmunología , Proteína Serina-Treonina Quinasas de Interacción con Receptores/metabolismo , Receptor Toll-Like 4/deficiencia , Yersiniosis/inmunología , Animales , Inhibidores Enzimáticos/farmacología , Gefitinib , Imidazoles/farmacología , Interleucina-10/biosíntesis , Macrófagos/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteína Adaptadora de Señalización NOD1/metabolismo , Proteína Adaptadora de Señalización NOD2/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Piridinas/farmacología , Pirimidinas/farmacología , Quinazolinas/farmacología , Proteína Serina-Treonina Quinasa 2 de Interacción con Receptor , Proteína Serina-Treonina Quinasas de Interacción con Receptores/antagonistas & inhibidores , Transducción de Señal/inmunología , Receptor Toll-Like 4/genética , Factor de Necrosis Tumoral alfa/biosíntesis , Yersinia enterocolitica
8.
Clin Exp Dermatol ; 37(7): 762-71, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22439751

RESUMEN

BACKGROUND: Pressure sores are lesions caused by impaired blood flow. Conventional dressings can absorb exudates, but do not promote wound healing. A hydrogel composed of ß-cyclodextrin (ß-CD), polyethyleneimine (PEI) and silk fibroin (SF) was assessed for use in healing of pressure sores. METHODS: The hydrogel was prepared by crosslinking ß-CD-grafted PEI and SF using epichlorohydrin. The gel was then immersed in an aqueous solution of Centella asiatica extract (CAE) 0.7 mg/mL and/or hydrocortisone acetate (HCA) 0.5 mg/mL. The in vivo pressure sore-healing efficacy of the dry gel (with or without the drugs) was investigated in terms of the hyperplasia of epidermis and the number of neutrophils in the skin tissue. RESULTS: The specific loading of CAE was 0.0091 g/g of dry gel. The percentage of CAE released at 24 h at pH 3.0, 5.0 and 7.4 was approximately 63.9%, 55.0% and 44.4%, respectively. This pH-dependent release is possibly due to the degree of gel swelling, which decreased with increasing pH. The specific loading of HCA was 0.0050 g/g dry gel, and the percentage release of HCA at 24 h was around 20% at all three pH points. It is likely that HCA release is independent of pH. HCA is a hydrophobic compound, and therefore the release of HCA is affected by the partitioning of HCA between the ß-CD cavity and the bulk water phase, but not by the degree of swelling of the hydrogel. The pressure sores treated with the hydrogel healed in 6 days, compared with 10 days for controls. CONCLUSIONS: In this study, a ß-CD/PEI/SF hydrogel containing CAE and HCA reduced the healing time for pressure sores.


Asunto(s)
Fibroínas/uso terapéutico , Hidrocortisona/análogos & derivados , Hidrogeles/uso terapéutico , Polietileneimina/uso terapéutico , Úlcera por Presión/tratamiento farmacológico , Triterpenos/uso terapéutico , beta-Ciclodextrinas/uso terapéutico , Animales , Centella , Hidrocortisona/uso terapéutico , Hidrogeles/síntesis química , Masculino , Ratones , Ratones Endogámicos ICR , Extractos Vegetales , Seda , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos
9.
Andrologia ; 44 Suppl 1: 796-803, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22212014

RESUMEN

This study investigated the protective effects of melatonin (MLT) against doxorubicin (DXR)-induced testicular toxicity and oxidative stress in rats. DXR was given as a single intraperitoneal dose of 10 mg kg(-1) body weight to male rats at 1 h after MLT treatment on day 6 of the study. MLT at 15 mg kg(-1) body weight was administered daily by gavage for 5 days before DXR treatment followed by an additional dose for 5 days. Sperm analysis, histopathological examination and biochemical methods were used for this investigation. DXR caused a decrease in the weight of seminal vesicles, epididymal sperm count and motility and an increase in the incidence of histopathological changes of the testis. In addition, an increased malondialdehyde (MDA) concentration and decreased glutathione content, glutathione reductase (GR), glutathione-S-transferase (GST), superoxide dismutase (SOD) and catalase activities were observed. On the contrary, MLT treatment significantly ameliorated DXR-induced testicular toxicity in rats. Moreover, MDA concentration and GR, GST and SOD activities were not affected when MLT was administered in conjunction with DXR. These results indicate that MLT had a protective effect against DXR-induced testicular toxicity and that the protective effects of MLT may be due to both the inhibition of lipid peroxidation and increased antioxidant activity.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Doxorrubicina/toxicidad , Melatonina/farmacología , Testículo/efectos de los fármacos , Animales , Catalasa/metabolismo , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Masculino , Malondialdehído/metabolismo , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/metabolismo , Testículo/enzimología , Testículo/metabolismo
10.
J Glob Health ; 12: 04069, 2022 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-35972943

RESUMEN

Background: The World Health Organization launched the International Classification of Diseases for Perinatal Mortality (ICD-PM) in 2016 to uniformly report on the causes of perinatal deaths. In this systematic review, we aim to describe the global use of the ICD-PM by reporting causes of perinatal mortality and summarizing challenges and suggested amendments. Methods: We systematically searched MEDLINE, Embase, Global Health, and CINAHL databases using key terms related to perinatal mortality and the classification for causes of death. We included studies that applied the ICD-PM and were published between January 2016 and June 2021. The ICD-PM data were extracted and a qualitative analysis was performed to summarize the challenges of the ICD-PM. We applied the PRISMA guidelines, registered our protocol at PROSPERO [CRD42020203466], and used the Appraisal tool for Cross-Sectional Studies (AXIS) as a framework to evaluate the quality of evidence. Results: The search retrieved 6599 reports. Of these, we included 15 studies that applied the ICD-PM to 44 900 perinatal deaths. Most causes varied widely; for example, "antepartum hypoxia" was the cause of stillbirths in 0% to 46% (median = 12%, n = 95) in low-income settings, 0% to 62% (median = 6%, n = 1159) in middle-income settings and 0% to 55% (median = 5%, n = 249) in high-income settings. Five studies reported challenges and suggested amendments to the ICD-PM. The most frequently reported challenges included the high proportion of antepartum deaths of unspecified cause (five studies), the inability to determine the cause of death when the timing of death is unknown (three studies), and the challenge of assigning one cause in case of multiple contributing conditions (three studies). Conclusions: The ICD-PM is increasingly being used across the globe and gives health care providers insight into the causes of perinatal death in different settings. However, there is wide variation in reported causes of perinatal death across comparable settings, which suggests that the ICD-PM is applied inconsistently. We summarized the suggested amendments and made additional recommendations to improve the use of the ICD-PM and help strengthen its consistency. Registration: PROSPERO [CRD42020203466].


Asunto(s)
Muerte Perinatal , Causas de Muerte , Estudios Transversales , Femenino , Humanos , Clasificación Internacional de Enfermedades , Muerte Perinatal/etiología , Mortalidad Perinatal , Embarazo , Mortinato/epidemiología
11.
Acta Anaesthesiol Scand ; 55(4): 452-9, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21391924

RESUMEN

BACKGROUND: Pulmonary dysfunction related to inflammatory response and radical oxygen species remains a problem in off-pump coronary bypass graft surgery (OPCAB), especially in patients with reduced left ventricular (LV) function. The aim of this study was to evaluate the effect of N-acetylcysteine (NAC) on pulmonary function following OPCAB. METHODS: Patients with LV ejection fraction ≤40% were randomly assigned to receive either a bolus of 100 mg/kg of intravenous NAC over a 15-min period immediately after anesthetic induction, followed by an intravenous infusion at 40 mg/kg/day for 24 h (NAC group, n=24), or a placebo (control group, n=24). Hemodynamic and pulmonary parameters, and the incidence of acute lung injury (PaO(2)/FiO(2)<300 mmHg) were assessed and compared. RESULTS: The pulmonary vascular resistance index (PVRI) did not change during mechanical heart displacement compared with the baseline value in the NAC group while it was significantly increased in the control group. Significantly less number of patients developed acute lung injury at 2 h after the surgery in the NAC group. The other pulmonary parameters and the duration of ventilator care were all similar. CONCLUSIONS: NAC demonstrated promising results in terms of mitigating the increase in PVRI during mechanical heart displacement and attenuating the development of acute lung injury in the immediate post-operative period. However, NAC could not induce a definite improvement in the other important pulmonary variables including PaO(2)/FiO(2) and Q(s)/Q(t), and did not lead to a decreased duration of ventilatory care or length of stay in the intensive care unit.


Asunto(s)
Acetilcisteína/farmacología , Puente de Arteria Coronaria Off-Pump , Depuradores de Radicales Libres/farmacología , Pulmón/fisiología , Lesión Pulmonar Aguda/epidemiología , Lesión Pulmonar Aguda/prevención & control , Anciano , Pérdida de Sangre Quirúrgica , Transfusión Sanguínea , Creatina Quinasa/sangre , Método Doble Ciego , Femenino , Hemodinámica/efectos de los fármacos , Humanos , Pulmón/efectos de los fármacos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/prevención & control , Circulación Pulmonar/efectos de los fármacos , Pruebas de Función Respiratoria , Resistencia Vascular/efectos de los fármacos , Disfunción Ventricular Izquierda/fisiopatología , Equilibrio Hidroelectrolítico/fisiología
12.
Lett Appl Microbiol ; 52(5): 532-7, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21362001

RESUMEN

AIMS: To determine whether glucose in growth medium affects secondary metabolite production and biocontrol efficacy of Pseudomonas chlororaphis O6. METHODS AND RESULTS: The secondary metabolites pyrrolnitrin and phenazines antagonize phytopathogenic fungi. The expression of the prnA gene encoding tryptophan halogenase, the first step in pyrrolnitrin biosynthesis, required the stationary-phase sigma factor, RpoS. Mutations in rpoS and prnA in Ps. chlororaphis O6 eliminated antifungal activity against Rhizoctonia solani and Fusarium graminearum. Pyrrolnitrin production was reduced by glucose in growth media, whereas phenazine levels were increased. The efficacy of Ps. chlororaphis O6 in the biocontrol of tomato late blight was reduced by addition of glucose to the growth medium. CONCLUSIONS: Regulation by glucose of pyrrolnitrin production influenced the efficacy of the biocontrol of tomato leaf blight. SIGNIFICANCE AND IMPACT OF THE STUDY: The nutritional regulation of secondary metabolite production from a soil pseudomonad may account, at least in part, for the variability of biocontrol under field conditions.


Asunto(s)
Antifúngicos/metabolismo , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Glucosa/farmacología , Fenazinas/metabolismo , Pirrolnitrina/metabolismo , Solanum lycopersicum/microbiología , Fusarium/efectos de los fármacos , Fusarium/metabolismo , Glucosa/metabolismo , Solanum lycopersicum/metabolismo , Miconazol/metabolismo , Pseudomonas/efectos de los fármacos , Pseudomonas/genética , Pseudomonas/crecimiento & desarrollo , Pseudomonas/metabolismo
13.
Tissue Antigens ; 76(4): 289-96, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20545903

RESUMEN

Several studies have showed an association of gene polymorphisms with the development of glomerulonephritis (GN). We investigated the effects of gene polymorphisms on the development of GN by analyzing polymorphisms in the interleukin (IL)-18, transforming growth factor (TGF)-ß, and vascular endothelial growth factor (VEGF) genes in Korean patients with primary GN. The study included 146 normal subjects (controls) and 100 patients diagnosed with primary GN by kidney biopsy. The gene polymorphisms A-607C and G-137C in IL-18, C-509T and T869C in TGF-ß1, and C-2578A and C405G in VEGF were investigated in DNA extracted from peripheral blood. Significant differences were observed between the GN and control groups in the genotype and allele frequencies of A-607C IL-18 and C405G VEGF. The frequencies of the IL-18-607CC genotype [P = 0.001, odds ratio (OR) = 2.473] and the VEGF 405GG genotype (P = 0.001, OR = 2.473) were significantly increased in the GN group. The combination of IL-18-607CC+ and VEGF 405GG+ genotypes had a higher risk for developing GN in comparison with the combination of IL-18-607CC- and VEGF 405GG- genotypes (P < 0.001, OR = 8.642). In the haplotype analysis of the IL-18 gene, the CG haplotype was significantly more frequent in the GN group than the control group (61.5% vs 46.9%, P = 0.002). These results show that the -607CC genotype of the IL-18 gene and the 405GG genotype of the VEGF gene are associated with susceptibility to and the development of primary GN.


Asunto(s)
Glomerulonefritis/genética , Interleucina-18/genética , Polimorfismo Genético , Factor de Crecimiento Transformador beta/genética , Factores de Crecimiento Endotelial Vascular/genética , Adulto , Pueblo Asiatico/genética , Femenino , Predisposición Genética a la Enfermedad , Haplotipos , Humanos , Masculino
14.
Lett Appl Microbiol ; 51(5): 511-7, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20849392

RESUMEN

AIMS: This study is aiming at characterizing antifungal substances from the methanol extract of Prunella vulgaris and at investigating those substances' antifungal and antioomycete activities against various plant pathogens. METHODS AND RESULTS: Two polyacetylenic acids were isolated from P. vulgaris as active principles and identified as octadeca-9,11,13-triynoic acid and trans-octadec-13-ene-9,11-diynoic acid. These two compounds inhibited the growth of Magnaporthe oryzae, Rhizoctonia solani, Phytophthora infestans, Sclerotinia sclerotiorum, Fusarium oxysporum f. sp. raphani, and Phytophthora capsici. In addition, these two compounds and the wettable powder-type formulation of an n-hexane fraction of P. vulgaris significantly suppressed the development of rice blast, tomato late blight, wheat leaf rust, and red pepper anthracnose. CONCLUSIONS: These data show that the extract of P. vulgaris and two polyacetylenic acids possess antifungal and antioomycete activities against a broad spectrum of tested plant pathogens. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report on the occurrence of octadeca-9,11,13-triynoic acid and trans-octadec-13-ene-9,11-diynoic acid in P. vulgaris and their efficacy against plant diseases. The crude extract containing the two polyacetylenic acids can be used as a natural fungicide for the control of various plant diseases.


Asunto(s)
Alquinos/farmacología , Antifúngicos/farmacología , Ácidos Grasos Insaturados/farmacología , Extractos Vegetales/farmacología , Prunella/química , Alquinos/análisis , Alquinos/aislamiento & purificación , Antifúngicos/análisis , Antifúngicos/aislamiento & purificación , Ácidos Grasos Insaturados/análisis , Ácidos Grasos Insaturados/aislamiento & purificación , Hongos/efectos de los fármacos , Hongos/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Phytophthora/efectos de los fármacos , Phytophthora/crecimiento & desarrollo , Enfermedades de las Plantas/microbiología , Enfermedades de las Plantas/parasitología , Extractos Vegetales/análisis , Extractos Vegetales/aislamiento & purificación
15.
J Glob Health ; 10(2): 020429, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33214899

RESUMEN

BACKGROUND: Maternal near-miss (MNM) is an important maternal health quality-of-care indicator. To facilitate comparison between countries, the World Health Organization (WHO) developed the "MNM-tool". However, several low- and middle-income countries have proposed adaptations to prevent underreporting, ie, Namibian and Sub-Sahara African (SSA)-criteria. This study aims to assess MNM and associated factors in middle-income country Suriname by applying the three different MNM tools. METHODS: A nationwide prospective population-based cohort study was conducted using the Suriname Obstetric Surveillance System (SurOSS). We included women with MNM-criteria defined by WHO-, Namibian- and SSA-tools during one year (March 2017-February 2018) and used hospital births (86% of total) as a reference group. RESULTS: There were 9114 hospital live births in Suriname in the one-year study period. SurOSS identified 71 women with WHO-MNM (8/1000 live births, mortality-index 12%), 118 with Namibian-MNM (13/1000 live births, mortality-index 8%), and 242 with SSA-MNM (27/1000 live births, mortality-index 4%). Namibian- and SSA-tools identified all women with WHO-criteria. Blood transfusion thresholds and eclampsia explained the majority of differences in MNM prevalence. Eclampsia was not considered a WHO-MNM in 80% (n = 35/44) of cases. Nevertheless, mortality-index for MNM with hypertensive disorders was 17% and the most frequent underlying cause of maternal deaths (n = 4/10, 40%) and MNM (n = 24/71, 34%). Women of advanced age and maroon ethnicity had twice the odds of WHO-MNM (respectively adjusted odds ratio (aOR) = 2.6, 95% confidence interval (CI) = 1.4-4.8 and aOR = 2.0, 95% CI = 1.2-3.6). The stillbirths rate among women with WHO-MNM was 193/1000births, with six times higher odds than women without MNM (aOR = 6.8, 95%CI = 3.0-15.8). While the prevalence and mortality-index differ between the three MNM tools, the underlying causes of and factors associated with MNM were comparable. CONCLUSIONS: The MNM ratio in Suriname is comparable to other countries in the region. The WHO-tool underestimates the prevalence of MNM (high mortality-index), while the adapted tools may overestimate MNM and compromise global comparability. Contextualized MNM-criteria per obstetric transition stage may improve comparability and reduce underreporting. While MNM studies facilitate international comparison, audit will remain necessary to identify shortfalls in quality-of-care and improve maternal outcomes.


Asunto(s)
Potencial Evento Adverso , Complicaciones del Embarazo , Nacimiento Prematuro , Adulto , Cesárea , Femenino , Humanos , Recién Nacido , Mortalidad Materna , Embarazo , Estudios Prospectivos , Indicadores de Calidad de la Atención de Salud , Suriname , Organización Mundial de la Salud , Adulto Joven
16.
J Appl Microbiol ; 106(4): 1213-9, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19120615

RESUMEN

AIMS: To characterize the volatile antifungal compound produced by Oxyporus latemarginatus EF069 and to examine in vitro and in vivo fumigation activity of the fungus. METHODS AND RESULTS: An antifungal volatile-producing strain, O. latemarginatus EF069 inhibited the mycelial growth of Alternaria alternata, Botrytis cinerea, Colletotrichum gloeosporioides, Fusarium oxysporum f. sp. lycopersici, and Rhizoctonia solani by mycofumigation. An antifungal volatile compound was isolated from the hexane extract of wheat bran-rice hull cultures of O. latemarginatus EF069 by repeated silica gel column chromatography and identified as 5-pentyl-2-furaldehyde (PTF). The purified PTF inhibited mycelial growth of R. solani in a dose-dependent manner. The mycofumigation with solid cultures of EF069 also reduced effectively the development of postharvest apple decay caused by B. cinerea and Rhizoctonia root rot of moth orchid caused by R. solani. CONCLUSIONS: Oxyporus latemarginatus EF069 showed in vitro and in vivo fumigation activity against plant pathogenic fungi by producing 5-pentyl-2-furaldehyde. SIGNIFICANCE AND IMPACT OF THE STUDY: Oxyporus latemarginatus EF069 producing an antifungal volatile compound may be used as a biofumigant for the control of fungal plant diseases.


Asunto(s)
Antifúngicos/farmacología , Botrytis/efectos de los fármacos , Hongos/química , Furaldehído/farmacología , Extractos Vegetales/farmacología , Rhizoctonia/efectos de los fármacos , Alternaria/efectos de los fármacos , Antifúngicos/química , Antifúngicos/aislamiento & purificación , Colletotrichum/efectos de los fármacos , Hongos/genética , Furaldehído/aislamiento & purificación , Fusarium/efectos de los fármacos , Malus/efectos de los fármacos , Micelio/efectos de los fármacos , Micelio/crecimiento & desarrollo , Orchidaceae/efectos de los fármacos , Control Biológico de Vectores , Enfermedades de las Plantas/microbiología , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Raíces de Plantas/efectos de los fármacos , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN
17.
J Appl Microbiol ; 106(6): 2057-63, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19245403

RESUMEN

AIMS: To characterize antifungal principles from the methanol extract of Magnolia obovata and to evaluate their antifungal activities against various plant pathogenic fungi. METHODS AND RESULTS: Four neolignans were isolated from stem bark of M. obovata as antifungal principles and identified as magnolol, honokiol, 4-methoxyhonokiol and obovatol. In mycelial growth inhibition assay, both magnolol and honokiol displayed more potent antifungal activity than 4-methoxyhonokiol and obovatol. Both magnolol and honokiol showed similar in vivo antifungal spectrum against seven plant diseases tested; both compounds effectively suppressed the development of rice blast, tomato late blight, wheat leaf rust and red pepper anthracnose. 4-Methoxyhonokiol and obovatol were highly active to only rice blast and wheat leaf rust respectively. CONCLUSIONS: The extract of M. obovata and four neolignans had potent in vivo antifungal activities against plant pathogenic fungi. SIGNIFICANCE AND IMPACT OF THE STUDY: Neolignans from Magnolia spp. can be used and suggested as a novel antifungal lead compound for the development of new fungicide and directly as a natural fungicide for the control of plant diseases such as rice blast and wheat leaf rust.


Asunto(s)
Antifúngicos/farmacología , Hongos/efectos de los fármacos , Lignanos/farmacología , Magnolia/química , Extractos Vegetales/farmacología , Compuestos Alílicos , Antifúngicos/química , Antifúngicos/aislamiento & purificación , Compuestos de Bifenilo , Cromatografía en Capa Delgada , Lignanos/química , Lignanos/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Micelio/efectos de los fármacos , Éteres Fenílicos , Corteza de la Planta/química , Enfermedades de las Plantas , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación
18.
J Appl Microbiol ; 104(3): 692-8, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17927749

RESUMEN

AIMS: To isolate and identify antioomycete substances from Fusarium oxysporum EF119 against Phytophthora infestans and to investigate their antimicrobial activities against various plant pathogenic bacteria, oomycetes and true fungi. METHODS AND RESULTS: Two antioomycete substances were isolated from liquid cultures of F. oxysporum EF119, which shows a potent disease control efficacy against tomato late blight caused by P. infestans. They were identified as bikaverin and fusaric acid by mass and nuclear magnetic resonance spectral analyses. They inhibited the mycelial growth of plant pathogenic oomycetes and fungi. Fusaric acid also effectively suppressed the cell growth of various plant pathogenic bacteria, but bikaverin was virtually inactive. Treatment with bikaverin at 300 microg ml(-1) suppressed the development of tomato late blight by 71%. Fusaric acid provided effective control against tomato late blight and wheat leaf rust over 67% at concentrations more than 100 microg ml(-1). CONCLUSIONS: Both bikaverin and fusaric acid showed in vitro and in vivo antioomycete activity against P. infestans. SIGNIFICANCE AND IMPACT OF THE STUDY: Fusarium oxysporum EF119 producing both bikaverin and fusaric acid may be used as a biocontrol agent against tomato late blight caused by P. infestans.


Asunto(s)
Microbiología de Alimentos , Fungicidas Industriales/farmacología , Ácido Fusárico/farmacología , Fusarium/química , Phytophthora/efectos de los fármacos , Xantonas/farmacología , Capsicum/microbiología , Ácido Fusárico/química , Extractos Vegetales/farmacología , Xantonas/química
20.
Endoscopy ; 39(5): 448-54, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17516352

RESUMEN

BACKGROUND AND STUDY AIMS: It is known that metal stent placement is safe, easy, and effective for the treatment of malignant colorectal obstruction, but these stents are associated with delayed complications of tumor ingrowth and stent migration. The aim of this study was to prospectively investigate the technical feasibility, clinical effectiveness, and safety of a dual-design colorectal stent (consisting of an outer stent and an inner bare nitinol stent) in patients with malignant colorectal obstruction. PATIENTS AND METHODS: Placement of the dual stent using a 4.5-mm stent delivery system was attempted in 151 patients with malignant colorectal obstruction, either before surgery (n = 50) or for palliation (n = 101). Multivariate logistic regression analysis was used to identify risk factors associated with complications. RESULTS: Stent placement was technically successful in 145/151 patients (96%). Of the patients who had a technically successful placement, bowel obstruction resolved within 2 days after stent placement in 48/50 (96%) of the patients in the bridge-to-surgery group and in 87/95 (92%) of the patients in the palliative group. Perforation occurred in 16 patients, incomplete stent expansion in eight patients, stent migration in four patients, tumor overgrowth in five patients, severe rectal pain in five patients, and bleeding in eight patients. Complete obstruction was the only significant risk factor for perforation (odds ratio 6.88, 95% CI 2.04-23.17, P = 0.002). In the palliative group, the median survival was 152.0 days and the mean survival was 263.8 days. CONCLUSIONS: The dual stent with a 4.5-mm stent delivery system is easy to insert, safe, and reasonably effective for the palliative treatment of malignant colorectal obstruction. However, a great deal of care is needed in its deployment because of the high rate of perforation.


Asunto(s)
Neoplasias Colorrectales/complicaciones , Obstrucción Intestinal/terapia , Stents , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Diseño de Equipo , Femenino , Estudios de Seguimiento , Migración de Cuerpo Extraño/etiología , Humanos , Obstrucción Intestinal/etiología , Obstrucción Intestinal/mortalidad , Perforación Intestinal/etiología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Dolor/etiología , Cuidados Paliativos , Estudios Prospectivos , Stents/efectos adversos , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA